Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 25;14(8):1514.
doi: 10.3390/genes14081514.

Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic RAI1 Variant

Affiliations
Review

Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic RAI1 Variant

Cathelijne C Linders et al. Genes (Basel). .

Abstract

Aim: Smith-Magenis syndrome (SMS) is a rare genetic neurodevelopmental disorder caused by a 17p11.2 deletion or pathogenic variant in the RAI1 gene. SMS is associated with developmental delay, intellectual disability (ID), and major sleep and behavioral disturbances. To explore how genetic variants may affect intellectual functioning and behavior, we compared intellectual and behavioral phenotypes between individuals with a 17p11.2 deletion and pathogenic RAI1 variant.

Method: We reviewed available clinical records from individuals (aged 0-45 years) with SMS, ascertained through a Dutch multidisciplinary SMS specialty clinic.

Results: We included a total of 66 individuals (n = 47, 71.2% with a 17p11.2 deletion and n = 19, 28.8% with a pathogenic RAI1 variant) for whom data were available on intellectual functioning, severity of ID (n = 53), and behavioral problems assessed with the Child Behavior Checklist (CBCL, n = 39). Median full-scale IQ scores were lower (56.0 vs. 73.5, p = 0.001) and the proportion of individuals with more severe ID was higher (p = 0.01) in the 17p11.2 deletion group. Median total CBCL 6-18 scores (73.5 vs. 66.0, p = 0.02) and scores on the sub-scales somatic complaints (68.0 vs. 57.0, p = 0.001), withdrawn/depressed behavior (69.5 vs. 55.0, p = 0.02), and internalizing behavior (66.0 vs. 55.0, p = 0.002) were higher in the RAI1 group.

Conclusion: The results of this study suggest that 17p11.2 deletions are associated with a lower level of intellectual functioning and less internalizing of problems compared to pathogenic RAI1 variants. The findings of this study may contribute to personalized-management strategies in individuals with SMS.

Keywords: 17p11.2 deletion; Smith–Magenis syndrome; behavioral problems; intellectual disability; pathogenic RAI1 variant; rare disorders.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflict of interest.

Figures

Figure 1
Figure 1
Full-scale IQ scores of 41 individuals with Smith–Magenis syndrome. Median FSIQ scores were lower in the group of individuals with a 17p11.2 deletion (56.0, range 45–92) compared to individuals with a pathogenic RAI1 variant (73.5, range 50–95, p = 0.001). Horizontal lines indicate median FSIQ scores. FSIQ = full-scale intelligence quotient.
Figure 2
Figure 2
ID severity in 53 individuals with Smith–Magenis syndrome. The dotted line represents a line to divide the individuals with borderline/mild from those with moderate/severe ID. The proportion of individuals with moderate/severe ID was higher in the 17p11.2 deletion group (22 out of 34; 64.7%) than in the group with a pathogenic RAI1 variant (5 out of 19; 26.3%, p = 0.01). ID = intellectual disability.

Similar articles

Cited by

References

    1. Elsea S.H., Girirajan S.S. Smith-Magenis Syndrome. Eur. J. Hum. Genet. 2008;16:412–421. doi: 10.1038/sj.ejhg.5202009. - DOI - PubMed
    1. Greenberg F., Guzzetta V., Montes de Oca-Luna R.M., Magenis R.E., Smith A.C.M., Richter S.F., Kondo I., Dobyns W.B., Patel P.I., Lupski J.R. Molecular Analysis of the Smith-Magenis Syndrome: A Possible Contiguous-Gene Syndrome Associated with del(17)(p11.2) Am. J. Hum. Genet. 1991;49:1207–1218. - PMC - PubMed
    1. Smith A.C.M., McGavran L., Waldstein G. Deletion of the 17 Short Arm in Two Patients with Facial Clefts. Am. J. Hum. Genet. 1982;34:A410.
    1. Slager R.E., Newton T.L., Vlangos C.N., Finucane B., Elsea S.H. Mutations in RAI1 Associated with Smith–Magenis Syndrome. Nat. Genet. 2003;33:466–468. doi: 10.1038/ng1126. - DOI - PubMed
    1. Finucane B., Haas-Givler B. Smith-Magenis Syndrome: Genetic Basis and Clinical Implications. J. Ment. Health Res. Intellect. Disabil. 2009;2:134–148. doi: 10.1080/19315860802627619. - DOI

Publication types

LinkOut - more resources